文献速递乳腺癌

深度学习改进乳腺癌组织学分级

Improved breast cancer histological grading using deep learning.
PubMed 文献 · Ann Oncol · 2021-09-29

本研究基于1567例患者常规H&E全切片图像开发并验证深度学习组织学分级模型DeepGrade,将NHG 2病例分为DG2-high和DG2-low两组。内部测试集中DG2-high较DG2-low复发风险升高(HR 2.94,95%CI 1.24-6.97,P=0.015),外部测试集验证复发风险升高(HR 1.91,95%CI 1.11-3.29,P=0.019)。

要点

  • DeepGrade基于全切片图像将NHG 2乳腺癌分为DG2-high与DG2-low两组。
  • 内部测试集DG2-high较DG2-low复发风险升高,HR 2.94(95%CI 1.24-6.97,P=0.015)。
  • 外部测试集DG2-high复发风险升高,HR 1.91(95%CI 1.11-3.29,P=0.019)。

核心结论

  • 基于DeepGrade模型对NHG 2肿瘤患者进行分层具有预后价值,在常规组织学分级之上提供有临床意义的信息。
  • 该方法为分子谱分析提供了一种成本效益较高的替代方案,以提取与临床决策相关的信息。

研究设计与样本

  • 观察性回顾性研究,利用1567例患者常规H&E染色全切片图像进行模型优化与验证。
  • 外部测试集纳入1262例患者进一步评估模型泛化性。
  • 将NHG 2病例分为DG2-high和DG2-low两组,评估预后价值,主要结局为无复发生存。

主要发现

  • 内部测试集中,校正已确立风险因素后,DG2-high较DG2-low复发风险升高(HR 2.94,95%CI 1.24-6.97,P=0.015)。
  • DG2-low与NHG 1表型相似,DG2-high与NHG 3表型相似。
  • 外部测试集中,DG2-high复发风险升高(HR 1.91,95%CI 1.11-3.29,P=0.019)。

临床怎么用

  • 作者认为基于该模型对NHG 2肿瘤患者进行分层具有预后价值,在常规组织学分级之上提供有临床意义的信息。
  • 作者认为该方法为分子谱分析提供了一种成本效益较高的替代方案,以提取与临床决策相关的信息。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Nottingham histological grade (NHG) is a well-established prognostic factor for breast cancer that is broadly used in clinical decision making. However, ∼50% of patients are classified as grade 2, an intermediate risk group with low clinical value. To improve risk stratification of NHG 2 breast cancer patients, we developed and validated a novel histological grade model (DeepGrade) based on digital whole-slide histopathology images (WSIs) and deep learning. PATIENTS AND METHODS: In this observational retrospective study, routine WSIs stained with haematoxylin and eosin from 1567 patients were utilised for model optimisation and validation. Model generalisability was further evaluated in an external test set with 1262 patients. NHG 2 cases were stratified into two groups, DG2-high and DG2-low, and the prognostic value was assessed. The main outcome was recurrence-free survival. RESULTS: DeepGrade provides independent prognostic information for stratification of NHG 2 cases in the internal test set, where DG2-high showed an increased risk for recurrence (hazard ratio [HR] 2.94, 95% confidence interval [CI] 1.24-6.97, P = 0.015) compared with the DG2-low group after adjusting for established risk factors (independent test data). DG2-low also shared phenotypic similarities with NHG 1, and DG2-high with NHG 3, suggesting that the model identifies morphological patterns in NHG 2 that are associated with more aggressive tumours. The prognostic value of DeepGrade was further assessed in the external test set, confirming an increased risk for recurrence in DG2-high (HR 1.91, 95% CI 1.11-3.29, P = 0.019). CONCLUSIONS: The proposed model-based stratification of patients with NHG 2 tumours is prognostic and adds clinically relevant information over routine histological grading. The methodology offers a cost-effective alternative to molecular profiling to extract information relevant for clinical decisions.

来源:Ann Oncol,查看原文。版权归原作者所有。

引用

  1. Wang Y, Acs B, Robertson S, et al. Improved breast cancer histological grading using deep learning. Ann Oncol. 2021. PMID: 34756513. doi:10.1016/j.annonc.2021.09.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。